Loading...

TOI ONCOLOGY INSTITUTE INC Capital Structure Changes 8-K Filing

NCLG

T

ONCOLOGY INSTITUTE INC

(TOI)

2023 8-K

Show Summary

Summary

Financial Results Announced

Director Resignation

Investor Meetings

Financial Statements

Nasdaq Compliance

Private Placement

Securities Agreement

Investor Presentation

Financial Results

Facility Agreement Amendment

Nasdaq Compliance Issue

Financial Results

Financial Results

Delisting Notice

Annual Meeting Stockholders

Earnings Report

Financial Results

Earnings Report

Earnings Report

Compliance Regained

Resignation of Director

Earnings Presentation

Financial Results Announcement

Annual Meeting of Stockholders

Share Repurchase Program

CEO Resignation and Appoint...

Departure of Directors or C...

Earnings Report

Delisting Notice

Earnings Presentation

Earnings Report

External Links:

The Oncology Institute, Inc. regained compliance with Nasdaq listing requirements after its common stock price was below $1.00 per share for 30 consecutive business days.

AI Assistant

ONCOLOGY INSTITUTE INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.